In early June, Salt Lake City had the distinction of hosting more than 5,100 physicians, technologists, and members of the molecular imaging and nuclear medicine communities as they gathered for the Society of Nuclear Medicine (SNM)’s 57th Annual Meeting.

Highlights of the meeting included lectures by leading nuclear medicine thinkers and researchers at the plenary sessions. The first, by Larry Kessler, Sc.D, professor and chair of the department of health services, School of Public Health, University of Washington, addressed the challenges and promise of evidence-based medicine with respect to molecular imaging and how the health policy and decision-making landscape may change. In his Cassen lectureship on the perspective of quantitative imaging, Sung-Cheng (Henry) Huang, D.Sc., a pioneer in the development of PET, noted that as imaging technology becomes more sophisticated, there is a greater need for approaches that can analyze the image data, extract biological information and determine its medical relevance.

Among the notable research presentations was an overview of molecular imaging techniques that are being used to identify the first signs of Alzheimer’s disease and research on the detection of recurrent prostate cancer.

The meeting was also used as an opportunity to recognize outstanding contributions to molecular imaging and neuroimaging. Bengt Roland Långström, Ph.D, a professor in the department of biochemistry and organic chemistry at Uppsala University in Sweden, was named as the recipient of the Georg Charles de Hevesy Nuclear Pioneer Award for his contributions to the nuclear medicine profession. Chester A. Mathis, Ph.D., director of the PET facility in the department of radiology at the University of Pittsburgh, received the Paul C. Aebersold Award for his long-standing work in the field of neuroimaging.

 

(Source: Press Release)